Form D · Other

Oakbio, Inc.

Sunnyvale, CA · CIK 0001833467

Offering snapshot reported Jul 24, 2024 · SEC filing

Reported sold
$17.3M
Offering amount: $23.3M
Investors reported
14
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jul 8, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 24, 2024Initial$17,284,998No comparison14SEC filing
Jul 15, 2021Amendment$9,281,200No comparisonNot reportedSEC filing
Feb 25, 2021Initial$6,273,197No comparison27SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-519581

Source: Form D, filed Jul 24, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Russell Howard Director
Alex Kopelyan Director
Mila Kyriacou Director
Brian Sefton Director, Executive
Kevin Tidwell Director
David Tze Director, Executive
Min Zhou Director

Issuer details

Industry: Other (See others in industry)

Address:
1292 Anvilwood Court
Sunnyvale, CA, 94089